BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways

scientific article

BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JCP.20013
P698PubMed publication ID15137061

P2093author name stringMing Zhou
He Huang
Jian Ma
Jie Zhou
Wei Xiong
Gui-Yuan Li
Shou-Rong Shen
Xiao-Ling Li
Bi-Cheng Zhang
Shi-Guo Zhu
Hua-Ying Liu
P2860cites workIsolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4Q24314643
BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19)Q24685696
Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signalsQ40023280
P433issue1
P304page(s)89-98
P577publication date2004-07-01
P1433published inJournal of Cellular PhysiologyQ1524270
P1476titleBRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways
P478volume200

Reverse relations

cites work (P2860)
Q46493497A genomic screen for angiosuppressor genes in the tumor endothelium identifies a multifaceted angiostatic role for bromodomain containing 7 (BRD7).
Q34585861A sex-specific role of type VII adenylyl cyclase in depression.
Q33247289BRD2 is one of BRD7-interacting proteins and its over-expression could initiate apoptosis
Q36118557BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma
Q51416712BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141.
Q55119106BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer.
Q24303120BRD7 is a candidate tumour suppressor gene required for p53 function
Q38760091BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-кB signaling pathway
Q33838482BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K
Q47414450BRD7 regulates the insulin-signaling pathway by increasing phosphorylation of GSK3β.
Q48079928BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways
Q37731459BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity
Q26751298BRD7: a novel tumor suppressor gene in different cancers
Q38788315Biological function and histone recognition of family IV bromodomain-containing proteins
Q35120841Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes
Q37086000Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma
Q24308923Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes
Q25255613Chromosomal imbalances in nasopharyngeal carcinoma: a meta-analysis of comparative genomic hybridization results
Q54933469Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains
Q37431423Disturbing miR-182 and -381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4.
Q38457229Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network
Q34514258Knockout of BRD7 results in impaired spermatogenesis and male infertility
Q27704896NMR Fragment Screening Hit Induces Plasticity of BRD7/9 Bromodomains
Q34611577Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis
Q36810352Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments
Q89944401Oral Exposure to Genistein during Conception and Lactation Period Affects the Testicular Development of Male Offspring Mice
Q92800638Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents
Q36662249Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus
Q54280630Prognostic relevance of BRD7 expression in colorectal carcinoma.
Q33367808Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells
Q35641383Retracted: Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7
Q37260036Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.
Q53280723TRIM proteins and cancer.
Q24316908TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells
Q33917573Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma
Q39455273The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma
Q38264787The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma
Q37117156The role of BRD7 in embryo development and glucose metabolism
Q24293463The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain
Q33396101Transcriptional regulation of BRD7 expression by Sp1 and c-Myc
Q42009542Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses
Q55449419[Expression and clinical significance of bromodomain-containing protein 7 in non-small cell lung cancer].
Q36775043miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma
Q39755104microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network
Q24685269LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-kappaB pathw

Search more.